Alzheimer’s drugs offer little benefit, major review finds – and the reasons go deeper than the science The Conversation
COMMENTS (0)
Starmer admits No 10 asked about job for aide Matthew DoyleHusband cleared of manslaughter over wife's suicideLufthansa cuts 20,000 summer flights as fuel prices surgeEU approves €90bn loan for Ukraine as pipeline is turned on ending deadlockThree ways the latest inflation figures affect you'Superstar' runners praised for helping exhausted man finish marathonMcDonald's boss on abuse claims: 'I don't want to talk about the past'Supreme Court rejects bid to revoke adoption of sistersUK set for Lyrid meteor shower display with clear skies forecastHay fever season is lasting longer - here's how to cope with itMonkeys 'learn to eat soil to cope with junk food'400 job applications but only three interviews - the jobseeker feeling 'ghosted' by employersFoo Fighters interview: 'We're a different band without Taylor Hawkins'Trump buys time for Iran deal after frantic day of diplomacyEngland's adaptive cheerleading champions chasing gold in Florida50 days until World Cup - pick your favourite kitsI was left with an £8,000 vet bill when my insurer cancelled my pet policyWhy police are seeking to arrest billionaire K-pop mogul behind BTSBeverley Callard forced to leave I'm A Celebrity: 'I didn't know I had cancer'Anthropic investigating claim of unauthorised access to Mythos AI toolMan, 77, slapped traffic warden and threatened to 'lump' herXbox cuts prices for Game Pass but ends day-one Call of Duty accessCar finance compensation scheme faces challenge and delayLos Angeles becomes first major US school district to limit classroom screen timeSouth Korean fighter jets collided due to pilots taking pictures, report findsBBC News appI Don’t Speak to My Family with Shaheen HashmatThe Prime Minister v Olly RobbinsDiscover the surprising wildlife of LondonRosenior position increasingly uncertain at Chelsea
Leave a Comment